Characterization and Hypoglycemic Activity of a Rhamnan-Type Sulfated Polysaccharide Derivative

Polysaccharide chromium (III) derivatives are gaining increasing attention in improving type 2 diabetes. In this study, the sulfated polysaccharide from Enteromorpha prolifera (SPE) with 4.8 kDa was prepared by specific enzymatic hydrolysis. The obtained SPE was used to prepare a rhamnan-type sulfat...

Full description

Bibliographic Details
Main Authors: Jie-Fen Cui, Han Ye, Yu-Jie Zhu, Yin-Ping Li, Jing-Feng Wang, Peng Wang
Format: Article
Language:English
Published: MDPI AG 2019-01-01
Series:Marine Drugs
Subjects:
Online Access:http://www.mdpi.com/1660-3397/17/1/21
_version_ 1798005732025565184
author Jie-Fen Cui
Han Ye
Yu-Jie Zhu
Yin-Ping Li
Jing-Feng Wang
Peng Wang
author_facet Jie-Fen Cui
Han Ye
Yu-Jie Zhu
Yin-Ping Li
Jing-Feng Wang
Peng Wang
author_sort Jie-Fen Cui
collection DOAJ
description Polysaccharide chromium (III) derivatives are gaining increasing attention in improving type 2 diabetes. In this study, the sulfated polysaccharide from Enteromorpha prolifera (SPE) with 4.8 kDa was prepared by specific enzymatic hydrolysis. The obtained SPE was used to prepare a rhamnan-type sulfated polysaccharide derivative (SPED). Results indicated that O-H, C=O, and S=O were effectively involved in the chelation of SPED (chromium content 20.26%). Acute (half lethal dose > 2.38 g/kg) and sub-acute toxicity showed that SPED had no damaging effects on mice. Anti-diabetic experiment demonstrated that SPED improved glucose metabolism. Moreover, SPED promoted the PI3K/PKB/GSK-3β signaling pathway by regulating mRNA expression of insulin receptors (IR), insulin receptor substrate 2 (IRS-2), phosphatidylinositol 3 kinase (PI3K), protein kinase B (PKB), and glycogen synthase kinase 3β (GSK-3β). In conclusion, the SPED might represent a novel marine-derived candidate against hyperglycemia, which may undergo further pharmaceutical development as a hypoglycemic agent.
first_indexed 2024-04-11T12:44:12Z
format Article
id doaj.art-616f905053c845598c9d01d0d421ece7
institution Directory Open Access Journal
issn 1660-3397
language English
last_indexed 2024-04-11T12:44:12Z
publishDate 2019-01-01
publisher MDPI AG
record_format Article
series Marine Drugs
spelling doaj.art-616f905053c845598c9d01d0d421ece72022-12-22T04:23:25ZengMDPI AGMarine Drugs1660-33972019-01-011712110.3390/md17010021md17010021Characterization and Hypoglycemic Activity of a Rhamnan-Type Sulfated Polysaccharide DerivativeJie-Fen Cui0Han Ye1Yu-Jie Zhu2Yin-Ping Li3Jing-Feng Wang4Peng Wang5College of Food Science and Engineering, Ocean University of China, Qingdao 266003, ChinaCollege of Food Science and Engineering, Ocean University of China, Qingdao 266003, ChinaCollege of Food Science and Engineering, Ocean University of China, Qingdao 266003, ChinaCollege of Food Science and Engineering, Ocean University of China, Qingdao 266003, ChinaCollege of Food Science and Engineering, Ocean University of China, Qingdao 266003, ChinaCollege of Food Science and Engineering, Ocean University of China, Qingdao 266003, ChinaPolysaccharide chromium (III) derivatives are gaining increasing attention in improving type 2 diabetes. In this study, the sulfated polysaccharide from Enteromorpha prolifera (SPE) with 4.8 kDa was prepared by specific enzymatic hydrolysis. The obtained SPE was used to prepare a rhamnan-type sulfated polysaccharide derivative (SPED). Results indicated that O-H, C=O, and S=O were effectively involved in the chelation of SPED (chromium content 20.26%). Acute (half lethal dose > 2.38 g/kg) and sub-acute toxicity showed that SPED had no damaging effects on mice. Anti-diabetic experiment demonstrated that SPED improved glucose metabolism. Moreover, SPED promoted the PI3K/PKB/GSK-3β signaling pathway by regulating mRNA expression of insulin receptors (IR), insulin receptor substrate 2 (IRS-2), phosphatidylinositol 3 kinase (PI3K), protein kinase B (PKB), and glycogen synthase kinase 3β (GSK-3β). In conclusion, the SPED might represent a novel marine-derived candidate against hyperglycemia, which may undergo further pharmaceutical development as a hypoglycemic agent.http://www.mdpi.com/1660-3397/17/1/21sulfated polysaccharide derivativestructure characterizationsafety evaluationtype 2 diabetesmolecular mechanism
spellingShingle Jie-Fen Cui
Han Ye
Yu-Jie Zhu
Yin-Ping Li
Jing-Feng Wang
Peng Wang
Characterization and Hypoglycemic Activity of a Rhamnan-Type Sulfated Polysaccharide Derivative
Marine Drugs
sulfated polysaccharide derivative
structure characterization
safety evaluation
type 2 diabetes
molecular mechanism
title Characterization and Hypoglycemic Activity of a Rhamnan-Type Sulfated Polysaccharide Derivative
title_full Characterization and Hypoglycemic Activity of a Rhamnan-Type Sulfated Polysaccharide Derivative
title_fullStr Characterization and Hypoglycemic Activity of a Rhamnan-Type Sulfated Polysaccharide Derivative
title_full_unstemmed Characterization and Hypoglycemic Activity of a Rhamnan-Type Sulfated Polysaccharide Derivative
title_short Characterization and Hypoglycemic Activity of a Rhamnan-Type Sulfated Polysaccharide Derivative
title_sort characterization and hypoglycemic activity of a rhamnan type sulfated polysaccharide derivative
topic sulfated polysaccharide derivative
structure characterization
safety evaluation
type 2 diabetes
molecular mechanism
url http://www.mdpi.com/1660-3397/17/1/21
work_keys_str_mv AT jiefencui characterizationandhypoglycemicactivityofarhamnantypesulfatedpolysaccharidederivative
AT hanye characterizationandhypoglycemicactivityofarhamnantypesulfatedpolysaccharidederivative
AT yujiezhu characterizationandhypoglycemicactivityofarhamnantypesulfatedpolysaccharidederivative
AT yinpingli characterizationandhypoglycemicactivityofarhamnantypesulfatedpolysaccharidederivative
AT jingfengwang characterizationandhypoglycemicactivityofarhamnantypesulfatedpolysaccharidederivative
AT pengwang characterizationandhypoglycemicactivityofarhamnantypesulfatedpolysaccharidederivative